MedTrace Logo

Impact of Expressive Touching During Embryo Transfer

NCT06590636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-09-19

No results posted yet for this study

Summary

Infertile individuals report psychiatric symptoms and that their levels of anxiety and depression are significantly higher than in fertile controls .Thus,this study aimed to determine the effect of expressive touching during embryo transfer on the anxiety and pregnancy rate.

Conditions

  • IVF-ET

Interventions

PROCEDURE

Expressive touching

Woman's anxiety level was measured with the State-Trait Anxiety Inventory scale Following these measurements, expressive touching that lasted 15-20 minutes was performed in the following manner. The hands of the expressive touching performer warmed to body temperature (should not be cold). The woman's hand close to the performer was placed between the hands of the expressive touching performer. The woman's palm was gently grasped with the palms of the expressive touching performer. The hand below was fixed and the upper part of the woman's hand was gently rubbed with the hand above. Before and after massaging, the woman's arms and shoulders were touched at intervals. During the procedure, the woman was called by her name, and verbal communication with the woman was continued by holding her hands firmly and sincerely as if a handshaking done. Before the woman's discharge from the center, her anxiety level was measured with the State-Trait Anxiety Inventory scale

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-05
Primary Completion
2023-09-05
Completion
2023-09-30

Countries

  • Palestinian Territories

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590636 on ClinicalTrials.gov